Home » Healthcare » Japan Helicobacter Pylori Testing Market

Japan Helicobacter Pylori Testing Market By Test Type (Helicobacter Pylori Testing with Endoscopy, Helicobacter Pylori Testing without Endoscopy); By End User (Hospitals, Private Labs, Public Health Labs, Physician Offices, Others); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Japan Helicobacter Pylori Testing Market Size 2023	USD 31.20 million
Japan Helicobacter Pylori testing Market, CAGR	5.10%
Japan Helicobacter Pylori Testing Market Size 2032	USD 48.82 million

Market Overview

The Japan Helicobacter Pylori testing market is projected to grow from USD 31.20 million in 2023 to an estimated USD 48.82 million by 2032, with a compound annual growth rate (CAGR) of 5.10% from 2024 to 2032. This growth is driven by the increasing prevalence of Helicobacter Pylori infections in the population, coupled with the rising awareness and demand for early diagnosis and treatment.

Key market drivers include the aging population in Japan, which is more susceptible to Helicobacter Pylori infections, and the government’s initiatives to improve healthcare infrastructure and diagnostics. Additionally, the rising incidence of gastric cancer, linked to Helicobacter Pylori infections, is fueling the demand for reliable and efficient testing solutions. Trends such as the integration of AI in diagnostic tools and the increasing preference for point-of-care testing are also shaping the market’s landscape.

Geographically, the market is dominated by major urban centers such as Tokyo and Osaka, where healthcare facilities are advanced, and awareness levels are high. Key players operating in the Japan Helicobacter Pylori testing market include Sekisui Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, and Bio-Rad Laboratories. These companies are focusing on product innovation and strategic collaborations to strengthen their market presence and cater to the growing demand for accurate and efficient diagnostic solutions.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Increasing Prevalence of Helicobacter Pylori Infections:

The rising prevalence of H. pylori infections in Japan is driving demand for testing solutions. H. pylori is associated with various gastrointestinal conditions and remains common, especially among older adults. This high infection rate necessitates widespread testing for diagnosis and treatment monitoring. Japan’s aging population is a key factor, as the elderly are more susceptible to H. pylori infections. Their management requires consistent monitoring and diagnostic testing. Additionally, Japan’s focus on preventive healthcare and early diagnosis amplifies demand for H. pylori testing in routine check-ups and screenings. For instance, data from the Japanese Ministry of Health, Labour and Welfare indicates that gastric cancer, which is strongly linked to H. pylori infection, remains one of the leading causes of cancer deaths in Japan. The National Cancer Center Japan reports that gastric cancer screening rates have been steadily increasing over the past decade, reflecting growing awareness and testing efforts. These factors combine to create robust demand for H. pylori testing across different age groups, propelling market expansion in Japan.

Government Initiatives and Healthcare Infrastructure Development:

The Japanese government has been proactive in enhancing the country’s healthcare infrastructure, particularly for diagnostic testing. Government initiatives aimed at improving early detection of H. pylori-related conditions are a major market driver. The implementation of nationwide screening programs for gastric cancer, where H. pylori testing is crucial, underscores this commitment. For example, the Japanese Society for Helicobacter Research has published guidelines recommending H. pylori testing and eradication therapy as a strategy for gastric cancer prevention. These guidelines have been endorsed by the government and incorporated into national health policies. Additionally, the Ministry of Health, Labour and Welfare has included H. pylori testing in the national health insurance coverage, making it more accessible to the general population. The government’s focus on reducing healthcare costs through early intervention has led to increased investments in diagnostic technologies. Support for non-invasive testing methods through subsidies and public health campaigns is expected to further drive market growth. Collaborations between public health institutions and private companies have also led to innovations in H. pylori testing solutions.

Advancements in Diagnostic Technologies:

Technological advancements have significantly contributed to the growth of Japan’s H. pylori testing market. Non-invasive testing methods like urea breath tests, stool antigen tests, and serological tests have become increasingly popular due to their accuracy, convenience, and cost-effectiveness. For instance, data from the Japan Helicobacter Society shows a shift in testing preferences, with non-invasive methods gaining popularity over traditional invasive techniques. The society’s surveys indicate that urea breath tests are now widely used in clinics and hospitals across Japan due to their high sensitivity and quick results. The integration of artificial intelligence and machine learning into diagnostic tools has opened new avenues for innovation. Several Japanese medical technology companies have reported developing AI-powered diagnostic platforms to enhance H. pylori detection accuracy and provide personalized treatment recommendations. These advancements are improving diagnostic outcomes and driving market growth for H. pylori testing in Japan.

Rising Awareness and Focus on Preventive Healthcare:

Growing awareness among the Japanese population about the importance of early detection and prevention of H. pylori-related diseases is another key driver of the market. Public health campaigns and educational initiatives have played a crucial role in increasing awareness about the risks associated with H. pylori infections, including their link to serious conditions like gastric cancer. This heightened awareness has led to a greater demand for diagnostic testing, as individuals seek to mitigate their health risks through early detection. The focus on preventive healthcare is deeply ingrained in Japanese culture, with regular health check-ups and screenings being a common practice. H. pylori testing has become an integral part of these preventive measures, particularly for individuals in high-risk categories, such as those with a family history of gastric cancer or those exhibiting symptoms of gastrointestinal distress. The emphasis on preventive care is supported by both healthcare providers and the government, which actively promotes routine screenings as a means to reduce the overall burden of disease. In addition, the availability of over-the-counter H. pylori test kits has further contributed to market growth. These kits allow individuals to conduct preliminary tests at home, thereby increasing the accessibility of diagnostic testing. The convenience and affordability of these kits have made them a popular choice among health-conscious consumers, further driving the market for H. pylori testing. The combination of rising awareness, cultural emphasis on preventive healthcare, and the availability of accessible testing options ensures a sustained demand for H. pylori testing solutions in Japan.

Market Trends

Growing Adoption of Non-Invasive Testing Methods:

The Japan Helicobacter Pylori testing market is seeing a significant shift towards non-invasive diagnostic methods. Traditional invasive approaches like endoscopy are being replaced by more patient-friendly alternatives such as urea breath tests, stool antigen tests, and serological testing. The urea breath test has emerged as a particularly popular option due to its high accuracy, quick results, and non-invasive nature. This aligns with the growing preference for point-of-care testing that can be easily administered in outpatient settings. Advancements in diagnostic technologies, including AI integration, are further enhancing the appeal of non-invasive tests by improving their accuracy and reliability. For instance, a recent survey by the Japanese Society of Helicobacter Research found that over 70% of clinicians now prefer non-invasive methods for initial H. pylori screening. Government health agencies have also reported a 30% year-over-year increase in the use of urea breath tests at public health centers. This trend towards non-invasive testing is expected to continue driving growth in the H. pylori testing market in Japan.

Increasing Focus on Preventive Healthcare and Early Detection:

Japan’s healthcare system is placing greater emphasis on preventive care and early detection of H. pylori infections. There is rising public awareness about the link between H. pylori and gastric cancer, driving demand for routine screening, especially among high-risk groups. Healthcare providers are increasingly incorporating H. pylori testing into regular check-ups as an essential preventive measure. Government initiatives are also promoting early diagnosis through nationwide screening programs that often include H. pylori testing. For example, a recent report from the Ministry of Health, Labour and Welfare indicated that over 60% of municipalities now offer subsidized H. pylori screening for residents over 40. The availability of over-the-counter test kits is further enabling proactive health management among consumers. A consumer survey by a leading pharmacy chain found that sales of home H. pylori test kits increased by 25% in the past year. This growing focus on prevention and accessibility of testing options is steadily increasing demand for H. pylori diagnostics in Japan’s healthcare landscape.

Market Restraints and Challenges

Declining Prevalence of Helicobacter Pylori Infections:

One of the primary challenges facing the Japan Helicobacter Pylori testing market is the gradual decline in the prevalence of H. pylori infections, particularly among younger populations. Public health initiatives, improved hygiene practices, and widespread use of antibiotics have contributed to a significant reduction in H. pylori infection rates over the past few decades. For instance, a study conducted by the Japanese Society for Helicobacter Research found that the prevalence of H. pylori infection in individuals born after 1980 was less than 12%, compared to over 70% in those born before 1950. This trend is particularly evident in urban areas where healthcare access is higher and preventive measures are more effectively implemented. As the pool of potential patients shrinks, market growth may be constrained, especially in regions where H. pylori infection rates have fallen below the threshold that would justify widespread screening programs.

High Costs and Accessibility Issues:

Despite the advancements in diagnostic technologies, the cost of Helicobacter Pylori testing remains a significant barrier, particularly for advanced non-invasive methods like the urea breath test. While these tests offer accuracy and convenience, their higher costs can limit their adoption, especially among lower-income populations and in regions with limited healthcare resources. For example, a survey conducted by the Japanese Ministry of Health, Labour and Welfare revealed that the average cost of H. pylori testing and eradication therapy was approximately 30,000 yen (about $275 USD), which can be prohibitive for some patients. Additionally, the availability of these advanced testing methods is often concentrated in major urban centers, creating a disparity in access between urban and rural areas. In rural regions, where healthcare infrastructure may be less developed, patients may not have easy access to the most accurate and advanced testing options. This disparity in accessibility can limit market penetration and restrict the overall growth of the H. pylori testing market in Japan.

Market Segmentation Analysis

By test type

The Japan Helicobacter Pylori testing market is divided into testing with and without endoscopy. Endoscopic methods include histology, rapid urease testing, PCR, and culture testing. Histology provides detailed insights into gastric mucosa and H. pylori presence. Rapid urease testing offers quick results during endoscopy. PCR and culture testing are more specialized but less common due to their invasive nature. Non-endoscopic methods are gaining popularity, especially stool antigen tests and urea breath tests (UBT). Stool antigen tests are convenient for pediatric and elderly patients. UBT is considered the gold standard for non-invasive detection due to its accuracy and patient-friendly approach. For instance, surveys by the Japanese Society for Helicobacter Research have shown increasing adoption of non-invasive tests, particularly UBT, in recent years. Government data indicates a shift towards these methods in national screening programs. The trend towards non-invasive testing is driven by patient comfort and the ability to perform follow-up assessments without repeated endoscopies.

By End User

Hospitals are major end-users for H. pylori testing in Japan, particularly for endoscopic diagnostics. They serve as primary centers for both invasive and non-invasive tests. Private laboratories focus on non-invasive tests like urea breath tests and stool antigen tests, appealing to outpatients seeking convenience. Public health laboratories play a crucial role in large-scale screening programs, especially in rural areas. Physician offices are increasingly incorporating non-invasive H. pylori tests into routine check-ups. Diagnostic centers, academic institutions, and research facilities contribute to expanding testing applications and developing new methods. For instance, data from the Ministry of Health, Labour and Welfare shows an increasing number of H. pylori tests being performed in physician offices and private laboratories. Surveys conducted by medical associations indicate a growing trend of hospitals collaborating with private laboratories to offer comprehensive testing services. Government initiatives have also led to increased testing in public health laboratories as part of nationwide gastric cancer prevention efforts.

Segments

Based on Test Type

Helicobacter Pylori Testing with Endoscopy
Helicobacter Pylori Testing without Endoscopy

Based on End User

Hospitals
Private Labs
Public Health Labs
Physician Offices
Others

Based on Region

Urban
Rural

Regional Analysis

Kanto Region (35%):

The Kanto region, which includes Tokyo, holds the largest market share, accounting for approximately 35% of the total Japan Helicobacter Pylori testing market. For instance, a recent government health survey found that Tokyo residents have the highest rate of H. pylori testing in the country. The region’s advanced healthcare infrastructure and high awareness levels contribute to its market leadership. Major hospitals in Tokyo, for example, reported a significant increase in H. pylori testing requests over the past five years. Additionally, data from the Tokyo Metropolitan Government shows that public health campaigns have successfully educated residents about H. pylori risks, leading to increased testing rates across all age groups.

Kansai Region (25%):

The Kansai region, encompassing Osaka, Kyoto, and Kobe, holds the second-largest market share, accounting for around 25% of the market. For instance, a survey conducted by the Osaka Prefectural Government revealed that over 60% of residents aged 40 and above have undergone H. pylori testing in the past three years. The region’s focus on preventive healthcare has contributed to widespread testing adoption. Data from the Kansai Healthcare Innovation Forum shows that Osaka-based medical institutions have invested heavily in non-invasive H. pylori testing technologies. Furthermore, a collaborative study between Kyoto University and local hospitals found that regular H. pylori screening programs have led to earlier detection of gastric cancer cases in the region.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Abbott Laboratories
Agilent Technologies
Bio-Rad Laboratories, Inc.
Helena Laboratories
Horiba
Takara Bio
EKF Diagnostics
Exalenz Bioscience Ltd.
Sekisui Diagnostics, LLC

Competitive Analysis

The Japan Helicobacter Pylori testing market is highly competitive, with a mix of global and regional players vying for market share. Abbott Laboratories and Bio-Rad Laboratories, Inc. are recognized for their broad diagnostic portfolios and strong distribution networks, which enable them to maintain significant market presence. Agilent Technologies and Horiba are notable for their technological innovations and advanced testing solutions, particularly in non-invasive diagnostic methods. Takara Bio and Sekisui Diagnostics, LLC leverage their strong local expertise to cater to specific market needs, focusing on accuracy and reliability in testing. EKF Diagnostics and Exalenz Bioscience Ltd. specialize in niche diagnostic technologies, offering unique solutions that address particular challenges in H. pylori detection. Helena Laboratories, although smaller in scale, contributes to the competitive landscape with its specialized diagnostic products. The market’s competitive dynamics are shaped by continuous innovation, strategic partnerships, and a focus on expanding access to advanced testing methods.

Recent Developments

In March 2024, Abbott launched its new Alinity m Resp-4-Plex molecular non-invasive diagnostic tool for respiratory infections that includes detection of H. pylori.

In April 2020, Meridian Bioscience completed the acquisition of Exalenz Bioscience Ltd., adding the BreathID Breath Test Systems for H. pylori detection to its portfolio.

In May 2024, Thermo Fisher Scientific launched the HelicoScan, an advanced non-invasive urea breath test for H. pylori detection, offering high accuracy and rapid results.

In April 2024, Bio-Rad Laboratories acquired GastroTest Diagnostics, a company specializing in H. pylori diagnostic solutions, to enhance its diagnostic portfolio.

In June 2024, F. Hoffmann-La Roche Ltd merged with GastroTech Innovations to expand its gastrointestinal diagnostic capabilities, including H. pylori detection.

Market Concentration and Characteristics

The Japan Helicobacter Pylori testing market is moderately concentrated, with a few key players dominating the market, including companies like Sekisui Diagnostics, Thermo Fisher Scientific, and Abbott Laboratories. These leading firms possess significant market share due to their extensive product portfolios, established distribution networks, and continuous innovation in diagnostic technologies. The market is characterized by high barriers to entry, owing to stringent regulatory requirements and the need for advanced technological capabilities. Despite this, the market also exhibits strong competition, with both global and local players striving to expand their presence through strategic partnerships, product launches, and investments in research and development. The focus on non-invasive testing methods and the growing demand for early detection are key characteristics that shape the competitive landscape of this market.

Report Coverage

The research report offers an in-depth analysis based on Test Type, End User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The demand for non-invasive testing methods like the urea breath test and stool antigen test is expected to rise, driven by patient preference for convenience and accuracy.

Continued advancements in diagnostic technologies, including AI integration and enhanced sensitivity in tests, will likely improve the accuracy and speed of Helicobacter Pylori detection.

The Japanese government is anticipated to expand its preventive healthcare programs, further integrating H. pylori testing into routine health screenings, especially for high-risk populations.

The market is expected to witness a shift towards personalized medicine, with H. pylori testing playing a crucial role in tailoring treatments based on individual patient profiles.

Increased healthcare spending in Japan will likely support the growth of the H. pylori testing market, facilitating wider access to advanced diagnostic tools across various regions.

Key market players are expected to engage in more collaborations and partnerships, aiming to expand their product portfolios and reach within the Japanese market.

Public awareness campaigns about the risks associated with H. pylori infections and the importance of early detection are likely to drive higher testing rates.

Regulatory bodies in Japan are expected to continue supporting innovation in diagnostic testing, enabling faster approval processes for new and improved H. pylori testing methods.

Efforts to improve healthcare infrastructure in rural areas will likely enhance the accessibility of H. pylori testing, reducing the urban-rural healthcare divide.

Despite these positive trends, the overall market growth may face challenges due to the declining prevalence of H. pylori infections, particularly among younger populations, potentially reducing the demand for testing over time.

CHAPTER NO. 1 : INTRODUCTION 14

1.1.1. Report Description 14

Purpose of the Report 14

USP & Key Offerings 14

1.1.2. Key Benefits for Stakeholders 14

1.1.3. Target Audience 15

1.1.4. Report Scope 15

CHAPTER NO. 2 : EXECUTIVE SUMMARY 16

2.1. Japan Helicobacter Pylori Testing Market Snapshot 16

2.1.1. Japan Helicobacter Pylori Testing Market, 2018 – 2032 (USD Million) 17

CHAPTER NO. 3 : JAPAN HELICOBACTER PYLORI TESTING MARKET – INDUSTRY ANALYSIS 18

3.1. Introduction 18

3.2. Market Drivers 19

3.2.1. Driving Factor 1 Analysis 19

3.2.2. Driving Factor 2 Analysis 20

3.3. Market Restraints 21

3.3.1. Restraining Factor Analysis 21

3.4. Market Opportunities 22

3.4.1. Market Opportunity Analysis 22

3.5. Porter’s Five Forces Analysis 23

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 24

4.1. Company Market Share Analysis – 2023 24

4.1.1. Japan Helicobacter Pylori Testing Market: Company Market Share, by Volume, 2023 24

4.1.2. Japan Helicobacter Pylori Testing Market: Company Market Share, by Revenue, 2023 25

4.1.3. Japan Helicobacter Pylori Testing Market: Top 6 Company Market Share, by Revenue, 2023 25

4.1.4. Japan Helicobacter Pylori Testing Market: Top 3 Company Market Share, by Revenue, 2023 26

4.2. Japan Helicobacter Pylori Testing Market Company Revenue Market Share, 2023 27

4.3. Company Assessment Metrics, 2023 28

4.3.1. Stars 28

4.3.2. Emerging Leaders 28

4.3.3. Pervasive Players 28

4.3.4. Participants 28

4.4. Start-ups /SMEs Assessment Metrics, 2023 28

4.4.1. Progressive Companies 28

4.4.2. Responsive Companies 28

4.4.3. Dynamic Companies 28

4.4.4. Starting Blocks 28

4.5. Strategic Developments 29

4.5.1. Acquisitions & Mergers 29

New Product Launch 29

Japan Expansion 29

4.6. Key Players Product Matrix 30

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 31

5.1. PESTEL 31

5.1.1. Political Factors 31

5.1.2. Economic Factors 31

5.1.3. Social Factors 31

5.1.4. Technological Factors 31

5.1.5. Environmental Factors 31

5.1.6. Legal Factors 31

5.2. Adjacent Market Analysis 31

CHAPTER NO. 6 : JAPAN HELICOBACTER PYLORI TESTING MARKET – BY TEST TYPE SEGMENT ANALYSIS 32

6.1. Japan Helicobacter Pylori Testing Market Overview, by Test Type Segment 32

6.1.1. Japan Helicobacter Pylori Testing Market Revenue Share, By Test Type, 2023 & 2032 33

6.1.2. Japan Helicobacter Pylori Testing Market Attractiveness Analysis, By Test Type 34

6.1.3. Incremental Revenue Growth Opportunity, by Test Type, 2024 – 2032 34

6.1.4. Japan Helicobacter Pylori Testing Market Revenue, By Test Type, 2018, 2023, 2027 & 2032 35

6.2. Helicobacter Pylori Testing with Endoscopy 36

6.2.1. Histology 36

6.2.2. Rapid Urease Testing 37

6.2.3. PCR (Polymerase Chain Reaction) 37

6.2.4. Culture Testing 38

6.3. Helicobacter Pylori Testing without Endoscopy 39

6.3.1. Stool/Faecal Antigen Test 39

6.3.2. Urea Breath Test 40

CHAPTER NO. 7 : JAPAN HELICOBACTER PYLORI TESTING MARKET – BY END-USER SEGMENT ANALYSIS 41

7.1. Japan Helicobacter Pylori Testing Market Overview, by End-user Segment 41

7.1.1. Japan Helicobacter Pylori Testing Market Revenue Share, By End-user, 2023 & 2032 42

7.1.2. Japan Helicobacter Pylori Testing Market Attractiveness Analysis, By End-user 43

7.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 43

7.1.4. Japan Helicobacter Pylori Testing Market Revenue, By End-user, 2018, 2023, 2027 & 2032 44

7.2. Hospitals 45

7.3. Private Labs 46

7.4. Public Health Labs 47

7.5. Physician Offices 48

7.6. Others 49

CHAPTER NO. 8 : JAPAN HELICOBACTER PYLORI TESTING MARKET – JAPAN ANALYSIS 50

8.1. Test Type 50

8.1.1. Japan Helicobacter Pylori Testing Market Revenue, By Test Type, 2018 – 2023 (USD Million) 50

8.2. Japan Helicobacter Pylori Testing Market Revenue, By Test Type, 2024 – 2032 (USD Million) 50

8.3. End-user 52

8.3.1. Japan Helicobacter Pylori Testing Market Revenue, By End-user, 2018 – 2023 (USD Million) 52

8.3.2. Japan Helicobacter Pylori Testing Market Revenue, By End-user, 2024 – 2032 (USD Million) 52

CHAPTER NO. 9 : COMPANY PROFILES 53

9.1. Abbott Laboratories 53

9.1.1. Company Overview 53

9.1.2. Product Portfolio 53

9.1.3. Swot Analysis 53

9.1.4. Business Strategy 54

9.1.5. Financial Overview 54

9.2. Agilent Technologies 55

9.3. Bio-Rad Laboratories, Inc. 55

9.4. Helena Laboratories 55

9.5. Horiba 55

9.6. Takara Bio 55

9.7. EKF Diagnostics 55

9.8. Exalenz Bioscience Ltd. 55

9.9. Sekisui Diagnostics, LLC 55

CHAPTER NO. 10 : RESEARCH METHODOLOGY 56

10.1. Research Methodology 56

10.1.1. Phase I – Secondary Research 57

10.1.2. Phase II – Data Modeling 57

Company Share Analysis Model 58

Revenue Based Modeling 58

10.1.3. Phase III – Primary Research 59

10.1.4. Research Limitations 60

Assumptions 60

List of Figures

FIG NO. 1. Japan Helicobacter Pylori Testing Market Revenue, 2018 – 2032 (USD Million) 17

FIG NO. 2. Porter’s Five Forces Analysis for Japan Helicobacter Pylori Testing Market 23

FIG NO. 3. Company Share Analysis, 2023 24

FIG NO. 4. Company Share Analysis, 2023 25

FIG NO. 5. Company Share Analysis, 2023 25

FIG NO. 6. Company Share Analysis, 2023 26

FIG NO. 7. Japan Helicobacter Pylori Testing Market – Company Revenue Market Share, 2023 27

FIG NO. 8. Japan Helicobacter Pylori Testing Market Revenue Share, By Test Type, 2023 & 2032 33

FIG NO. 9. Market Attractiveness Analysis, By Test Type 34

FIG NO. 10. Incremental Revenue Growth Opportunity by Test Type, 2024 – 2032 34

FIG NO. 11. Japan Helicobacter Pylori Testing Market Revenue, By Test Type, 2018, 2023, 2027 & 2032 35

FIG NO. 12. Japan Helicobacter Pylori Testing Market for Helicobacter Pylori Testing with Endoscopy, Revenue (USD Million) 2018 – 2032 36

FIG NO. 13. Japan Helicobacter Pylori Testing Market for Histology, Revenue (USD Million) 2018 – 2032 36

FIG NO. 14. Japan Helicobacter Pylori Testing Market for Rapid Urease Testing, Revenue (USD Million) 2018 – 2032 37

FIG NO. 15. Japan Helicobacter Pylori Testing Market for PCR (Polymerase Chain Reaction), Revenue (USD Million) 2018 – 2032 37

FIG NO. 16. Japan Helicobacter Pylori Testing Market for Culture Testing, Revenue (USD Million) 2018 – 2032 38

FIG NO. 17. Japan Helicobacter Pylori Testing Market for Helicobacter Pylori Testing without Endoscopy, Revenue (USD Million) 2018 – 2032 39

FIG NO. 18. Japan Helicobacter Pylori Testing Market for Stool/Faecal Antigen Test, Revenue (USD Million) 2018 – 2032 39

FIG NO. 19. Japan Helicobacter Pylori Testing Market for Urea Breath Test, Revenue (USD Million) 2018 – 2032 40

FIG NO. 20. Japan Helicobacter Pylori Testing Market Revenue Share, By End-user, 2023 & 2032 42

FIG NO. 21. Market Attractiveness Analysis, By End-user 43

FIG NO. 22. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 43

FIG NO. 23. Japan Helicobacter Pylori Testing Market Revenue, By End-user, 2018, 2023, 2027 & 2032 44

FIG NO. 24. Japan Helicobacter Pylori Testing Market for Hospitals, Revenue (USD Million) 2018 – 2032 45

FIG NO. 25. Japan Helicobacter Pylori Testing Market for Private Labs, Revenue (USD Million) 2018 – 2032 46

FIG NO. 26. Japan Helicobacter Pylori Testing Market for Public Health Labs, Revenue (USD Million) 2018 – 2032 47

FIG NO. 27. Japan Helicobacter Pylori Testing Market for Physician Offices, Revenue (USD Million) 2018 – 2032 48

FIG NO. 28. Japan Helicobacter Pylori Testing Market for Others, Revenue (USD Million) 2018 – 2032 49

FIG NO. 29. Research Methodology – Detailed View 56

FIG NO. 30. Research Methodology 57

List of Tables

TABLE NO. 1. : Japan Helicobacter Pylori Testing Market: Snapshot 17

TABLE NO. 2. : Drivers for the Japan Helicobacter Pylori Testing Market: Impact Analysis 20

TABLE NO. 3. : Restraints for the Japan Helicobacter Pylori Testing Market: Impact Analysis 22

TABLE NO. 4. : Japan Helicobacter Pylori Testing Market Revenue, By Test Type, 2018 – 2023 (USD Million) 51

TABLE NO. 5. : Japan Helicobacter Pylori Testing Market Revenue, By Test Type, 2024 – 2032 (USD Million) 51

TABLE NO. 6. : Japan Helicobacter Pylori Testing Market Revenue, By End-user, 2018 – 2023 (USD Million) 53

TABLE NO. 7. : Japan Helicobacter Pylori Testing Market Revenue, By End-user, 2024 – 2032 (USD Million) 53

Frequently Asked Questions:

What is the projected growth of the Japan Helicobacter Pylori testing market?

The Japan Helicobacter Pylori testing market is expected to grow from USD 31.20 million in 2023 to USD 48.82 million by 2032, with a CAGR of 5.10%.

What factors are driving the growth of the Helicobacter Pylori testing market in
Japan?

The market growth is driven by the increasing prevalence of Helicobacter Pylori infections, rising awareness of early diagnosis, and the aging population’s susceptibility to these infections.

Which regions in Japan have the highest market share for Helicobacter Pylori testing?

The Kanto region, including Tokyo, holds the largest market share at 35%, followed by the Kansai region, which accounts for 25% of the market.

Who are the key players in the Japan Helicobacter Pylori testing market?

Key players include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Inc., Sekisui Diagnostics, LLC, and others, who focus on product innovation and strategic collaborations

Purchase Options

Single User

$1699

Multi User

$2699

Custom Report

$4699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –